Drug Type Cell therapy |
Synonyms Autologous bone marrow-derived mononuclear cells (BMMNCs), BMMNCs |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alveolar Bone Loss | Clinical | China | 01 Nov 2022 | |
| Bone defects | Clinical | China | 01 Nov 2022 |





